Capricor Therapeutics
CAPR
$4.64
Share price
-3.13%
Change (1 day)
-5.69%
Change (1 year)
Categories
Capricor Therapeutics (CAPR) - Total liabilities
Total liabilities on the balance sheet as of March 2024 : $31 M
According to Capricor Therapeutics 's latest financial reports the company's total liabilities are $31 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Capricor Therapeutics - Total liabilities on balance sheet (from 2001 to 2024)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $36.13 M | -5.68% |
| 2022-12-31 | $38.3 M | 284.54% |
| 2021-12-31 | $9.96 M | 55.2% |
| 2020-12-31 | $6.41 M | 50.18% |
| 2019-12-31 | $4.27 M | -7.71% |
| 2018-12-31 | $4.63 M | -8.23% |
| 2017-12-31 | $5.04 M | -77.82% |
| 2016-12-31 | $22.75 M | 33.03% |
| 2015-12-31 | $17.1 M | -13.98% |
| 2014-12-31 | $19.88 M | 227.38% |
| 2013-12-31 | $6.07 M | 1047.61% |
| 2012-12-31 | $0.52 M | -2.27% |
| 2011-12-31 | $0.54 M | -49.35% |
| 2010-12-31 | $1.06 M | 67.69% |
| 2009-12-31 | $0.63 M | -52.13% |
| 2008-12-31 | $1.33 M | -29.51% |
| 2007-12-31 | $1.88 M | 1301.86% |
| 2006-12-31 | $0.13 M | 73% |
| 2005-12-31 | $0.07 M | 31.16% |
| 2004-12-31 | $0.05 M | 42.22% |
| 2003-12-31 | $0.04 M | 70.09% |
| 2002-12-31 | $0.02 M | 167.33% |
| 2001-12-31 | $0 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $101.94 B | 328,657.32% | 🇺🇸 USA |
 Neurocrine Biosciences
NBIX | $1.08 B | 3,403.12% | 🇺🇸 USA |
 Cytokinetics
CYTK | $1.20 B | 3,783.46% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | $30.23 M | -2.50% | 🇺🇸 USA |
 Palatin Technologies PTN | $9.82 M | -68.31% | 🇺🇸 USA |
 Eterna Therapeutics ERNA | $53.06 M | 71.14% | 🇺🇸 USA |